Ardent Health (ARDT) Cash from Financing Activities (2023 - 2026)

Ardent Health's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at -$11.8 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 14.79% year-over-year to -$11.8 million; the TTM figure through Mar 2026 stood at -$101.4 million (down 446.21% YoY), while the FY2025 annual figure was -$103.5 million, down 519.87% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$11.8 million, up from -$37.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $183.4 million in Q3 2024, with the low at -$119.8 million in Q2 2024.
• The 4-year median for Cash from Financing Activities is -$20.5 million (2024), against an average of -$12.0 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 867.13% in 2024, then tumbled 114.68% in 2025.
• Ardent Health's Cash from Financing Activities stood at -$17.9 million in 2023, then fell by 14.48% to -$20.5 million in 2024, then sank by 80.88% to -$37.0 million in 2025, then soared by 68.19% to -$11.8 million in 2026.
• Business Quant data shows ARDT's Cash from Financing Activities at -$11.8 million in Q1 2026, -$37.0 million in Q4 2025, and -$26.9 million in Q3 2025.